This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 2048761 results found since Jan 2013.

Continuing Medical Education (CME) questions: HbF induction in {beta}-thalassemia
Source: Blood - March 21, 2013 Category: Hematology Tags: CME article Continuing Medical Education (CME) Questions Source Type: research

Clinician uptake of obesity-related drug information: A qualitative assessment using continuing medical education activities
Conclusions: Clinicians' knowledge of medication-related weight gain may lead them to overestimate the benefits of a drug in relation to its metabolic risks. The knowledge base of pediatricians appears comparable to their counterparts in adult medicine, even though metabolic drug effects in children have only become prevalent recently.
Source: Nutrition Journal - April 10, 2013 Category: Nutrition Authors: Ingrid KohlstadtGerold Wharton Source Type: research

Continuing Medical Education (CME) questions: HLA Abs and platelet refractoriness
Source: Blood - April 18, 2013 Category: Hematology Tags: CME article Continuing Medical Education (CME) Questions Source Type: research

What's new in pediatric dermatology? Part I. Diagnosis and pathogenesis
The field of pediatric dermatology has been rich in new developments. Part I of this continuing medical education article will focus on new diagnoses and new insights into the etiology and pathogenesis of pediatric skin disorders. Insights into the pathogenesis of atopic dermatitis, new forms of contact dermatitis, recently recognized mimickers of port wine stains, associations with infantile hemangiomas, the concept of genetic diseases being classified by common pathways (RASopathies), newly recognized genetic discoveries in mosaic disorders, the recognition of cystic fibrosis being associated with aquagenic wrinkling of ...
Source: Journal of the American Academy of Dermatology - May 24, 2013 Category: Dermatology Authors: Howard B. Pride, Megha Tollefson, Robert Silverman Tags: Continuing Medical Education Source Type: research

What's new in pediatric dermatology? Part II. Treatment
The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections,...
Source: Journal of the American Academy of Dermatology - May 24, 2013 Category: Dermatology Authors: Howard B. Pride, Megha Tollefson, Robert Silverman Tags: Continuing Medical Education Source Type: research

Continuing Medical Education (CME) questions: MYC/BCL2 coexpression in diffuse large B-cell lymphoma
Source: Blood - May 16, 2013 Category: Hematology Tags: CME article Continuing Medical Education (CME) Questions Source Type: research

Maintenance of Certification in dermatology: What we know, what we don't
Participation in Maintenance of Certification is a reality for the majority of board-certified physicians in the United States. It consists of 4 parts that focus the attention of participants on knowledge assessment, practice performance, communication skills, and patient safety. This continuing medical education article reviews the development and possible future of the program, data regarding Maintenance of Certification, what is currently not known about Maintenance of Certification, and how to navigate the requirements for dermatologists.
Source: Journal of the American Academy of Dermatology - June 15, 2013 Category: Dermatology Authors: Erik Stratman, Robert S. Kirsner, Thomas D. Horn Tags: Continuing Medical Education Source Type: research

Continuing Medical Education (CME) questions: Thrombosis in PNH
Source: Blood - June 20, 2013 Category: Hematology Tags: CME article CONTINUING MEDICAL EDUCATION (CME) QUESTIONS Source Type: research

Continuing medical education program: Journal of Pediatric surgery–CME featured articles in this issue
Source: Journal of Pediatric Surgery - June 1, 2013 Category: Surgery Tags: Continuing Medical Education Program Journal of Pediatric Surgery-CME Featured Articles In This Issue Source Type: research

Primary cutaneous B-cell lymphomas: Part II. Therapy and future directions
The choice of therapy for primary cutaneous B-cell lymphoma (PCBCL) relies on correct histopathologic classification and the exclusion of systemic disease. In part II of this continuing medical education article, we will review the available therapies for the different types of PCBCL. Primary cutaneous follicle center lymphoma (PCFCL) and primary cutaneous marginal zone lymphoma (PCMZL) are indolent tumors with an excellent prognosis. They are managed similarly with local therapy, such as radiotherapy or surgical excision, for isolated disease and observation for asymptomatic multifocal presentations. Relapses are common i...
Source: Journal of the American Academy of Dermatology - August 22, 2013 Category: Dermatology Authors: Andrea Luísa Suárez, Christiane Querfeld, Steven Horwitz, Melissa Pulitzer, Alison Moskowitz, Patricia L. Myskowski Tags: Continuing Medical Education Source Type: research

Kawasaki disease: Part II. Complications and treatment
Kawasaki disease, or mucocutaneous lymph node syndrome, is the leading cause of acquired heart disease in children in the United States and other developed countries. Coronary artery lesions are the most significant cause of morbidity and mortality. Treatment should ideally be provided within 10 days of symptom onset to reduce the risk of coronary artery complications. The standard of care for treatment is intravenous immunoglobulin plus aspirin, but adding corticosteroids may provide additional benefit for high-risk patients. Some patients do not respond to intravenous immunoglobulin and require additional therapy. Part I...
Source: Journal of the American Academy of Dermatology - September 20, 2013 Category: Dermatology Authors: Stephanie Bayers, Stanford T. Shulman, Amy S. Paller Tags: Continuing Medical Education Source Type: research

Continuing Medical Education Program in Transfusion.
Authors: PMID: 24099341 [PubMed - as supplied by publisher]
Source: Transfusion - October 1, 2013 Category: Hematology Tags: Transfusion Source Type: research

Changing Nature of Continuing Medical Education.
PMID: 24093686 [PubMed - as supplied by publisher]
Source: Orthopedics - October 1, 2013 Category: Orthopaedics Authors: Hak DJ Tags: Orthopedics Source Type: research

Obtaining rapid and effective hemostasis: Part I. Update and review of topical hemostatic agents
Effective and rapid hemostasis is critical to optimize surgical outcomes. An advantageous adjunct in accelerating the clotting process during dermatologic surgery is the use of topical hemostatic agents, which allow dermatologic surgeons to quickly clear the surgical field while avoiding the adverse effects of systemic medications. The growing rate of patients with pacemakers and defibrillators limits the possibility of electrosurgery. It is not unusual for patients to be taking ≥1 anticoagulant medication(s). For these reasons, the use of topical hemostatic agents is likely to gain more recognition in the literature. Th...
Source: Journal of the American Academy of Dermatology - October 17, 2013 Category: Dermatology Authors: Nicole Howe, Basil Cherpelis Tags: Continuing Medical Education Source Type: research

Obtaining rapid and effective hemostasis: Part II. Electrosurgery in patients with implantable cardiac devices
Electrosurgery is an integral part of dermatology that is commonly used both to obtain hemostasis and to treat cutaneous lesions. However, it can cause many complications in patients with implantable devices. Because of the risk of electromagnetic interference, a variety of precautions are commonly used. Not only are there no consistent community-based standards in place regarding the performance of electrosurgery in patients with implantable devices, but these precautions are largely based upon anecdotal experience or recommendations from different specialties. To further complicate matters, the literature regarding elect...
Source: Journal of the American Academy of Dermatology - October 17, 2013 Category: Dermatology Authors: Nicole Howe, Basil Cherpelis Tags: Continuing Medical Education Source Type: research